Currently out of the existing stock ratings of Caitlin Cronin, 44 are a BUY (69.84%), 19 are a HOLD (30.16%).

Caitlin Cronin

Work Performance Price Targets & Ratings Chart

Analyst Caitlin Cronin, currently employed at CANACCORD, carries an average stock price target met ratio of 57.09% that have a potential upside of 32.14% achieved within 122 days.

Caitlin Cronin’s has documented 123 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on BVS, Bioventus at 17-Aug-2026.

Wall Street Analyst Caitlin Cronin

Analyst best performing recommendations are on KRMD (REPRO MED SYSTEMS).
The best stock recommendation documented was for SNN (SMITH & NEPHEW SNATS) at 5/11/2026. The price target of $30 was fulfilled within 1 day with a profit of $0.9 (3.09%) receiving and performance score of 30.93.

Average potential price target upside

ATEC Alphatec Holdings AXGN Axogen BVS Bioventus ENOV Enovis Corp ESTA Establishment Labs Holdings GMED Globus Medical INMD InMode Ltd KRMD Repro Med Systems SNN Smith & Nephew SNATS VCEL Vericel Corp Ord TELA Tela Bio

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 28-Jul-2026

$16

$5.97 (59.52%)

$15

2 months ago
(05-Aug-2026)

0/2 (0%)

$6.43 (67.19%)

Buy Since 19-Oct-2020

$13

$2.97 (29.61%)

$11

2 months ago
(05-Aug-2026)

6/10 (60%)

$3.43 (35.84%)

255

Buy Since 01-Aug-2024

$12

$1.97 (19.64%)

$11

2 months ago
(05-Aug-2026)

2/4 (50%)

$2.43 (25.39%)

234

Buy Since 09-Mar-2026

$13

$2.97 (29.61%)

$20

2 months 27 days ago
(08-Jul-2026)

1/4 (25%)

$3.79 (41.15%)

13

Buy Since 05-Aug-2019

$14

$3.97 (39.58%)

$14

4 months 7 days ago
(28-May-2026)

19/23 (82.61%)

$6.11 (77.44%)

542

Show more analysts

Please expand the browser size to see the chart

Which stock is Caitlin Cronin most bullish on?

Potential upside of $27.23 has been obtained for ENOV (ENOVIS CORP)

Which stock is Caitlin Cronin most reserved on?

Potential downside of $3.58 has been obtained for SNN (SMITH & NEPHEW SNATS)

What Year was the first public recommendation made by Caitlin Cronin?

On 2023
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?